In this line, it has been proposed that resistin can activate different signaling pathways such as mitogen-activated protein kinase (MAPK), Akt, and P1K3, increasing the proliferation of cancer cells and activating the NFkB signaling pathway, which can increase levels of IL-6-inducing metastatic processes [219]. The gene discussed is AKT1; the disease is cancer.